Saturday, December 6, 2025

Tablets and Capsules

 

TABLET DOSAGE FORM – FORMULATION NOTES

1. Definition (Lachman & Mehta)

A tablet is a solid unit dosage form containing one or more medicaments with or without excipients, obtained by compression or molding.

Key features:
Accurate dose
Most stable dosage form
Easy to administer & mass-produce
Good patient compliance

2. Advantages & Disadvantages (Lachman)

Advantages

  • Accuracy & uniformity of dose
  • Lower production cost
  • Compact, stable, portable
  • Coating improves aesthetics & compliance
  • Modified release possible

Disadvantages

  • Poor wetting or slow dissolution (problem for poorly soluble drugs)
  • Compression issues for high-dose drugs
  • Bioavailability affected by GI conditions and excipients
  • Not suitable for unconscious patients and those with dysphagia

3. Types of Tablets (Lachman, RM Mehta)

A. By Route

  • Oral tablets: compressed, film-coated, sugar-coated, enteric-coated, chewable, dispersible, effervescent, buccal, sublingual, ODT
  • Parenteral: implantation tablets
  • Vaginal: vaginal tablets/pessaries

B. By Release Pattern

  • Immediate release (IR)
  • Modified release (sustained/controlled/extended)
  • Delayed release (enteric)
  • Targeted release

Mnemonics: "COFFEE BEDS"
C – Chewable
O – ODT
F – Film-coated
F – Fast dissolving
E – Effervescent
E – Enteric
B – Buccal
E – Extended release
D – Delayed
S – Sublingual

4. Tablet Formulation Components (Excipients)

(Lachman, Mehta, Brahmankar)

Tablets = API + Excipients
Excipients ensure compressibility, flow, stability, palatability, disintegration, dissolution.

4.1 Excipients Classification

1. Diluents / Fillers

Used when API dose is small.

Examples:

  • Lactose (monohydrate, spray-dried)
  • MCC (Avicel PH101/102)
  • Dicalcium phosphate (DCP)
  • Mannitol (chewables)
  • Starch

Properties: good compressibility, non-reactive
DCP: Non-hygroscopic, but insoluble → slower dissolution

2. Binders / Granulating Agents

Improve cohesiveness during compression.

Examples:

  • PVP (Povidone)
  • HPMC
  • Starch paste (10–20%)
  • Gelatin solution
  • Sucrose syrup

3. Disintegrants

Help breakup of tablet upon contact with fluids.

Superdisintegrants:

  • CrosPovidone (CP)
  • Croscarmellose sodium (CCS)
  • Sodium starch glycolate (SSG)

Mechanisms:
Swelling
Porosity wicking
Deformation recovery

4. Lubricants

Reduce friction between tablet and die wall.

Examples:

  • Magnesium stearate
  • Stearic acid
  • Sodium stearyl fumarate

Over-lubrication → ↓ hardness, ↓ dissolution (important MCQ).

5. Glidants

Improve flow of powder during compression.

Examples:

  • Colloidal silicon dioxide
  • Talc

6. Anti-adherents

Prevent sticking to punch faces.

Examples: talc, starch

7. Colorants, Flavors, Sweeteners

  • Colors: FDA certified lakes
  • Flavors: mint, fruit
  • Sweeteners: aspartame, saccharin, sorbitol

5. Tablet Manufacturing Processes (Lachman)

There are 3 core methods:

5.1 Direct Compression (DC)

Drug + Excipients → Blend → Compress

Requirements

  • API must have good compressibility + flow
  • Use DC grades (e.g., spray-dried lactose, MCC)

Advantages

  • Simple, fewer steps
  • Faster, cost-effective
  • Moisture/heat-sensitive drugs

Disadvantages

  • Not suitable for low-dose or poorly compressible drugs

5.2 Dry Granulation

Two methods:

  • Slugging (using large tablets)
  • Roller Compaction

Drug + Excipients → Slug/Roll compact → Milling → Lubrication → Compress

Used for:

  • Moisture/heat-sensitive drugs
  • Poorly compressible API

5.3 Wet Granulation

Drug + Binder → Wet Mass → Screen → Drying → Sizing → Lubrication → Compression

Advantages

  • Good flow, compressibility
  • Minimizes segregation
  • Suitable for low-dose drugs

Disadvantages

  • Costly, time consuming
  • Not suitable for moisture/heat-sensitive drugs

6. Tablet Defects (Lachman, RM Mehta)

During Compression

  • Capping — top part separates
  • Lamination — layers form
  • Cracking — improper moisture, too much pressure
  • Sticking — granules stick to punches
  • Picking — material sticks in engraving
  • Chipping — small breakage at edges
  • Mottling — color variation

Mnemonics: "CLCS CPM"

C – Capping
L – Lamination
C – Cracking
S – Sticking
C – Chipping
P – Picking
M – Mottling

7. Evaluation of Tablets (Pre- & Post-compression)

7.1 Pre-compression Tests

  • Angle of repose
  • Bulk density
  • Tapped density
  • Carr’s index
  • Hausner ratio
  • Particle size analysis
  • Moisture content

7.2 Post-compression Tests

1. Weight Variation Test (IP/BP/USP)

For ≥ 25 mg drug or 25% of tablet weight.

Limits:
± 5%: >250 mg
± 7.5%: 130–250 mg
± 10%: <130 mg

2. Hardness Test

Ideal: 4–10 kg/cm²

3. Friability

≤ 1% acceptable

4. Thickness & Diameter

5. Disintegration

Uncoated tablets: <15 minutes (IP)
Enteric-coated: No disintegration in 0.1 N HCl for 2 h

6. Dissolution

USP Apparatus I/II
Q = amount dissolved in fixed time (e.g., Q = 80% in 30 min)

7. Assay & Content Uniformity

8. Factors Affecting Tablet Bioavailability

(Brahmankar & Wolters Kluwer)

Formulation factors:

  • Disintegration time
  • Dissolution rate
  • Particle size
  • Polymorphism
  • Excipients (lubricant level, binder type)
  • Compression force (↑ force → slow dissolution)

Drug factors:

  • Solubility, Log P
  • pKa
  • Stability in GI fluids
  • First-pass metabolism

9. Special Tablets

Enteric-coated tablets

Coating polymers:

  • Cellulose acetate phthalate (CAP)
  • HPMC phthalate
  • Shellac

Sustained-release tablets

Mechanisms:

  • Matrix (HPMC, EC)
  • Osmotic pumps (OROS)
  • Coated systems
  • Ion exchange resins

10. Tablet Packaging

  • Blister packs (PVC, PVDC)
  • Strip packaging
  • Bottles (HDPE with desiccants)

11. Flowchart: Tablet Formulation (Exam Direct)

API → Preformulation → Choice of Method (DC/Wet/DRG) 
→ Excipients selection → Granulation → Drying 
→ Sizing → Blending → Lubrication 
→ Compression → Coating (optional) 
→ Evaluation → Packaging

MNEMONICS (High-yield for exams)

Excipients order (Typical):

"D-B-D-L-G-A-C"
D – Diluent
B – Binder
D – Disintegrant
L – Lubricant
G – Glidant
A – Anti-adherent
C – Color/flavor

Tablet Defects: “CLCS CPM”

C – Capping
L – Lamination
C – Cracking
S – Sticking
C – Chipping
P – Picking
M – Mottling

Superdisintegrants: “3 Cs + S”

CCS – Croscarmellose
CP – Crospovidone
SSG – Sodium starch glycolate

 

CAPSULE DOSAGE FORM – COMPLETE NOTES

1. Definition (Lachman, Mehta)

A capsule is a solid unit dosage form in which drug substances are enclosed within either a hard or soft soluble container or shell, usually made of gelatin.

Used for solids, semisolids, liquids (in soft-gel), pellets, microgranules
Capsule masks taste/odor and offers flexibility in formulation

2. Advantages & Disadvantages

Advantages

  • Good patient acceptability
  • Masks unpleasant taste/odor
  • Better bioavailability than tablets (less compression)
  • Can fill powders, pellets, small tablets, liquids (SGC)
  • Elegant appearance
  • Easy to formulate and customize dose
  • Protects sensitive drugs (light-, moisture-sensitive)

Disadvantages

  • Costlier than tablets
  • Hygroscopic, moisture-sensitive APIs incompatible with gelatin
  • Capsule shells become brittle in < 35% RH
  • Not suitable for children and dysphagic patients
  • Risk of tampering (requires sealing)

3. Types of Capsules

A. Hard Gelatin Capsules (HGC)

Shell components:

  • Gelatin (80–85%)
  • Water (10–15%)
  • Dyes/pigments
  • Opacifiers (titanium dioxide)
  • Preservatives (rare)
  • Plasticizers (small amounts)

Grade: Type A (acid-treated collagen) or Type B (alkali-treated collagen)

Designs:

  • Cap + Body → friction fit
  • Snap-fit (IMPROVES LOCK)
  • Coni-snap (tapered body for easy filling)

B. Soft Gelatin Capsules (SGC)

Shell composition:

  • Gelatin
  • Plasticizers (glycerin, sorbitol)
  • Water
  • Preservatives
  • Colorants, opacifiers

Used for:
Oils, hydrophobic liquids
Suspensions
Self-emulsifying drug systems
Vitamins, essential oils

C. Special Capsules

  • Enteric-coated capsules
  • Sustained-release capsules
  • Liquid-filled HPMC capsules
  • DRcaps (delayed-release)
  • Inhalation capsules (Rotacaps)
  • Sprinkle capsules (pellets inside)

4. Capsule Sizes (Lachman)

For human use: Sizes 000, 00, 0, 1, 2, 3, 4, 5.

Size

Capacity (mg for moderately dense powder)

000

1000 mg

00

600–800 mg

0

400–500 mg

1

300–400 mg

2

200–300 mg

3

150–200 mg

4

120–150 mg

5

60–100 mg

Mnemonic: “Big → Small: 000 to 5”
Size 0 is most commonly used in industry

5. Formulation of Hard Gelatin Capsules

5.1 Ingredients added to the capsule contents

Based on Lachman (Industrial Pharmacy) and RM Mehta.

A. Diluents/Fillers

Used to increase bulk when API dose is low.
Examples:

  • Lactose (monohydrate)
  • MCC
  • Starch
  • Dicalcium phosphate
  • Mannitol (chewables)

B. Glidants

Improve flow into capsule body.

  • Colloidal silicon dioxide
  • Talc

C. Lubricants (for powder flow, not die lubrication)

  • Magnesium stearate
  • Stearic acid

D. Wetting agents

For poorly wetting drugs (e.g., hydrophobic APIs)

  • Sodium lauryl sulfate (SLS)

E. Disintegrants

If capsule releases pellets/tablets inside

  • Croscarmellose sodium
  • SSG
  • Crospovidone

6. Capsule Manufacturing & Filling (HGC)

6.1 HGC Shell Manufacturing (Lachman)

Dip-coating process:

  1. Stainless steel mould pins dipped in gelatin solution
  2. Rotated → uniform coating
  3. Dried in controlled humidity
  4. Stripped off
  5. Trimmed
  6. Cap & body joined
  7. Sorted by size & defects

6.2 Filling Operations

Methods:

A. Hand filling (hand filling machine)

Used in pharm labs and small-scale.

B. Semi-automatic machines

Parts: rectification → separation → filling → joining → ejection

C. Automatic capsule filling machines

Filling types:

  • Powder plug method
  • Dosator-nozzle method
  • Tamping pin method
  • Auger filling (for cohesive powders)
  • Pellet filling
  • Tablet filling
  • Liquid/semi-solid filling (special capsules)

7. Soft Gelatin Capsule Filling (SGC)

Fill material must be:
Non-aqueous
Compatible with gelatin
Low water activity

Examples:

  • Vegetable oils
  • PEG-based liquids
  • Self-emulsifying drug delivery systems (SEDDS)
  • Vitamins (A, D, E, K)

SGC Manufacturing:

Rotary die process
→ Two gelatin ribbons
→ Formed + filled + sealed in a single operation

8. Capsule Sealing

Used to prevent tampering & leakage.

Types:

  • Band sealing (gelatin band)
  • Heat welding
  • Liquid sealing (hydroalcoholic glue)

9. Capsule Stability Issues

Gelatin absorbs moisture → shell softening
Low humidity → shell becomes brittle
Ideal RH: 35–45%
Stored in well-closed containers with desiccants.

10. Incompatibilities

Capsule shells incompatible with:

  • Highly hygroscopic materials
  • Efflorescent powders
  • Volatile solvents
  • Strong alkaline materials

Solutions:
Use HPMC capsules
Use double-shell capsules
Seal capsules

11. Capsule Evaluation Tests

A. Physicochemical Tests

  • Appearance & defects
  • Weight variation
  • Lock integrity
  • Moisture permeability
  • Shell thickness (SGC)

B. Disintegration Test

Uncoated capsules: <30 min (IP)
Enteric-coated: No disintegration in acid for 2 h, then disintegrates in buffer.

C. Dissolution

Same as tablets: USP I/II
Pellets inside capsules have modified dissolution profiles.

D. Content Uniformity

Required for low-dose drugs.

E. Microbial tests

Applicable for SGC (higher moisture).

12. Bioavailability Considerations (Brahmankar)

Capsules often show faster disintegration and better bioavailability than compressed tablets.

Factors affecting BA:

  • Shell dissolution rate
  • Pellet size
  • Lubricant levels
  • Liquid-based fills show enhanced BA

13. Capsule Defects (Important for DI Exam)

1. Brittleness

Low moisture content
→ Shell cracks

2. Softening & Stickiness

High humidity
→ Shell absorbs moisture

3. Splits & Fractures

During filling or handling

4. Dented/Deformed capsules

Due to machine impact or poor drying

5. Leakage in SGCs

Improper sealing or formulation incompatibility

14. Flowchart – Capsule Formulation (Exam Direct)

API → Preformulation → Selection of capsule type (HGC/SGC) 
→ Excipient selection → Filling → Sealing (if needed) 
→ Evaluation (weight, disintegration, dissolution) 
→ Packaging (blisters/bottles with desiccants)

High-Yield Mnemonics

Capsule Shell Composition (HGC)

“G-WOP”
G – Gelatin
W – Water
O – Opacifiers
P – Pigments

SGC Components

“GPP-WC”
G – Gelatin
P – Plasticizer
P – Preservative
W – Water
C – Colorant

Filling Methods

“P-D-T-A”
P – Plug method
D – Dosator
T – Tamping pin
A – Auger

Capsule Defects

“BSSDL”
B – Brittle
S – Softened
S – Splits
D – Dented
L – Leaking

 

 

 

No comments:

Post a Comment

Composition, Responsibilities, Procedures Of IRB/IEC

🧬 Composition, Responsibilities, and Procedures of IRB / IEC 🔷 Introduction An IRB (Institutional Review Board) or IEC (Independe...